[1]
Jovanovska, A., Martinova, K., Kocheva, S., Trajkova-Antevska, Z., Coneska-Jovanova, B., Panovska-Stavridis, I., Stankovikj, S., Trajkova, S. and Dimovski, A. 2019. Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia. Open Access Macedonian Journal of Medical Sciences. 7, 17 (Sep. 2019), 2818–2823. DOI:https://doi.org/10.3889/oamjms.2019.752.